Ligand Pharmaceuticals LGND Captisol — Inventory
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's captisol — inventory.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's captisol — inventory?
- Ligand Pharmaceuticals (LGND) reported captisol — inventory of $1.8M in Q1 2026.
- How has Ligand Pharmaceuticals's captisol — inventory changed year-over-year?
- Ligand Pharmaceuticals's captisol — inventory decreased by 35.7% year-over-year, from $2.8M to $1.8M.
- What is the long-term trend for Ligand Pharmaceuticals's captisol — inventory?
- Over 3 years (2022 to 2025), Ligand Pharmaceuticals's captisol — inventory has grown at a -43.1% compound annual growth rate (CAGR), from $53.3M to $9.8M.
- What does captisol — inventory mean?
- The total value of raw materials, work-in-progress, and finished goods associated with the Captisol product line held by the company. Monitoring this balance helps assess supply chain efficiency and the company's ability to meet anticipated demand for its formulation technology.